Sertindole Paroxetine

CjnHjzFNOj 110429-36-2) see Paroxetine 1 -(4-fluorophenyl)-S-chloro- Iff-indole (C14H9CIFN 138900-22-8) see Sertindole... 

Cyt 2D6 metabolizes haloperidol, risperidone, thioridazine, sertindole, olanzapine and clozapine common substrates - fluoxetine, paroxetine, sertraline, venlafaxine, amitriptyline, clomipramine, desipramine, imipramine, nortriptyline, propranolol, metoprolol, timolol, codeine, encainide, flecanide. Common inhibitors - paroxetine, sertraline, fluoxetine. 

CYP2D6 Antidepressants amitriptyline, clomipramine, imipramine, desipramine, nortriptyline, trimipramine, N-desmethyl-clomipramine, fluoxetine, norfluoxetine, paroxetine, venlafaxine, sertraline Neuroleptics chlorpromazine, thioridazine, perphenazine, haloperidol, reduced haloperidol, risperidone, clozapine, sertindole Others codeine, opiate, propranolol, dextromethorphan 4 no activity 25% in Caucasians 0%-10% in others 5 no activity 2%-10% in all groups 10 reduced activity 47%-70% in Asians <5% in others 17 reduced activity 25%-40% in blacks 0% in others 2XN increased activity 19%-29% in Arabs and Ethiopians <5% in others... 

The manufacturers of sertindole contraindicate the concurrent use of cimetidine, diltiazem, erythromycin, itraconazole, ketoco-nazole, terfenadine and verapamil because of an increased risk of cardiac arrhythmias. Carbamazepine and phenytoin reduce plasma sertindole levels whereas fluoxetine and paroxetine increase them. No clinically relevant interactions occur with alprazolam, antacids, food or tobacco smoking. 

Fluoxetine and paroxetine are inhibitors of the cytochrome P450 isoenzyme CYP2D6. Concurrent use results in a two- to three-fold increase in sertindole plasma levels. The manufacturers advise that low maintenance doses of sertindole may be needed and recommend close ECG monitoring when doses are adjusted. An isolated case report describes a man with paranoid psychosis and imipolar depression whose condition unexpectedly seriously worsened when paroxetine was stopped while continuing to take sertindole. ... 

Walker-Kinnear M, McnNaughton S. Paroxetine discontinuation syndrome in association with sertindole therapy. BrJPsychiatry (1997) 170, 389,... 

---